See March's 10 most read stories, including Filipino researchers' study of virgin coconut oil as a potential treatment for COVID-19, how firms should communicate immune-boosting properties of micronutrients to consumers, and more.
Click...
India’s three-week lockdown has affected the nutrition and health businesses on multiple fronts, most directly on the production, supply chain, and e-commerce delivery, companies including FMCG giant and ayurvedic medicine specialist Dabur have told us.
In this round-up, we shine the spotlight on Singapore's clampdown on products that claim to have COVID-19 health claims, South Korea's new rules for functional ingredients use, and how the Indian state of Odisha is the first to exercise nutrition...
An Indian start-up specialising in making protein bread and cookies saw online sales go up by 15% in mid March, with the firm believing consumers are increasingly making more healthy food choices as COVID-19 continues to spread.
Singapore’s national regulator for health products, the Health Sciences Authority (HSA), has removed a significant number of product listings claiming to prevent or treat COVID-19 from local e-commerce platforms.
Entries have been flowing in for NutraIngredients-Asia's third annual awards, held to recognise the best supplements and functional foods products, ingredients and research across Asia Pacific.
In light of the ongoing COVID-19 health situation, FoodBnavigator-Asia and NutraIngredients-Asia has rescheduled the Healthy Ageing APAC Summit from July 7-9 to November 10-12, 2020, at the Hilton hotel in Singapore.
The dietary supplement industry bodies in both Australia and New Zealand are seeking clarification that the sector is classed as an ‘essential service’, with both countries imposing movement restriction to curb the spread of COVID-19.
There is widespread confusion among Malaysia’s dietary supplement industry as to whether it is considered an essential service and production can continue under the country’s coronavirus lockdown.
This round-up focuses on the vitamin C sales surge in China due to COVID-19, the addition of three 'blue-hat' probiotics formulation to Sirio Pharma and more.
